Details for New Drug Application (NDA): 205352
✉ Email this page to a colleague
The generic ingredient in ALEVE PM is diphenhydramine hydrochloride; naproxen sodium. There are twenty-three drug master file entries for this compound. Twenty-two suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride; naproxen sodium profile page.
Summary for 205352
Tradename: | ALEVE PM |
Applicant: | Bayer Hlthcare |
Ingredient: | diphenhydramine hydrochloride; naproxen sodium |
Patents: | 0 |
Pharmacology for NDA: 205352
Mechanism of Action | Cyclooxygenase Inhibitors Histamine H1 Receptor Antagonists |
Suppliers and Packaging for NDA: 205352
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
ALEVE PM | diphenhydramine hydrochloride; naproxen sodium | TABLET;ORAL | 205352 | NDA | Bayer HealthCare LLC. | 0280-1200 | 0280-1200-01 | 1 BOTTLE in 1 CARTON (0280-1200-01) / 120 TABLET, FILM COATED in 1 BOTTLE |
ALEVE PM | diphenhydramine hydrochloride; naproxen sodium | TABLET;ORAL | 205352 | NDA | Bayer HealthCare LLC. | 0280-1200 | 0280-1200-02 | 2 TABLET, FILM COATED in 1 POUCH (0280-1200-02) |
Profile for product number 001
Active Rx/OTC/Discontinued: | OTC | Dosage: | TABLET;ORAL | Strength | 25MG;220MG | ||||
Approval Date: | Jan 17, 2014 | TE: | RLD: | Yes |
Complete Access Available with Subscription